COM:DIAMEDICA
DiaMedica Therapeutics Inc.
- Stock
Last Close
4.18
22/11 16:29
Market Cap
113.89M
Beta: -
Volume Today
38.65K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | -0.00 - | -0.00 0% | 44K - | 49K 11.36% | 61.50K 25.51% | 56.50K 8.13% | ||||||
average payables | 781.90K - | 666.03K 14.82% | 816.17K 22.54% | 499.49K 38.80% | 419.81K 15.95% | 498K 18.62% | 332.50K 33.23% | 640.50K 92.63% | 804K 25.53% | 621.50K 22.70% | 830K 33.55% | |
average receivables | 17.43K - | 11.37K 34.74% | 9.00K 20.90% | 30.78K 242.19% | 65.99K 114.37% | 430K 551.64% | 801.50K 86.40% | 581.50K 27.45% | 235K 59.59% | 106K 54.89% | 41K 61.32% | |
book value per share | 0.51 - | -0.49 197.27% | -0.34 31.07% | 0.26 177.57% | 0.13 48.84% | 2.20 1,533.35% | 0.64 71.10% | 1.66 161.10% | 2.12 27.74% | 1.20 43.21% | 0.00 99.87% | |
capex per share | -0.05 - | -0.01 79.49% | -0.00 85.26% | -0.00 2.08% | -0.00 154.64% | -0.01 74.22% | -0.00 97.42% | -0.00 1,696.59% | -0.00 64.67% | -0.00 189.24% | -0.00 99.98% | |
capex to depreciation | -0.12 - | -12.69 10,369.55% | -1.31 89.68% | -3.14 139.54% | -5.50 75.22% | -3.33 39.39% | -0.10 97.14% | -2.24 2,250% | -0.92 59.04% | -3.24 253.45% | 0.02 100.62% | |
capex to operating cash flow | 0.02 - | 0.01 65.81% | 0.00 52.71% | 0.00 42.20% | 0.01 147.41% | 0.01 55.61% | 0.00 97.50% | 0.01 2,228.76% | 0.00 64.91% | 0.01 291.88% | 0.00 81.79% | |
capex to revenue | -0.10 - | |||||||||||
cash per share | 0.92 - | 0.07 92.89% | 0.05 30.30% | 0.37 702.09% | 0.23 37.83% | 2.17 853.12% | 0.66 69.75% | 1.75 166.94% | 2.17 23.79% | 1.27 41.66% | 0.00 99.87% | |
days of inventory on hand | ||||||||||||
days payables outstanding | ||||||||||||
days sales outstanding | 569.40 - | |||||||||||
debt to assets | 0.00 - | 0.02 1,467.74% | 0.00 78.64% | 0.00 72.82% | 0.01 1,094.46% | 0.01 45.84% | ||||||
debt to equity | 0.00 - | 0.02 1,629.80% | 0.00 80.59% | 0.00 73.96% | 0.01 1,147.57% | 0.01 46.83% | ||||||
dividend yield | ||||||||||||
earnings yield | -0.18 - | -1.55 779.47% | -0.21 86.49% | -0.21 1.87% | -0.15 31.08% | -0.25 73.03% | -0.18 28.02% | -0.08 57.79% | -0.18 126.90% | -0.33 86.60% | -0.00 99.94% | |
enterprise value | 39.51M - | 2.90M 92.65% | 6.72M 131.51% | 8.68M 29.18% | 27.61M 218.05% | 5.73M 79.24% | 54.44M 849.40% | 151.71M 178.69% | 72.83M 51.99% | 37.52M 48.48% | 92.49B 246,389.27% | |
enterprise value over ebitda | -6.26 - | -0.60 90.40% | -4.85 707.57% | -3.84 20.83% | -6.45 67.93% | -1.04 83.82% | -5.08 386.66% | -12.16 139.44% | -5.35 56.04% | -2.68 49.79% | -4.76K 177,254.51% | |
ev to operating cash flow | -7.18 - | -0.77 89.23% | -4.92 536.54% | -2.87 41.64% | -7.08 146.54% | -1.01 85.78% | -5.98 494.13% | -16.52 176.17% | -5.94 64.01% | -3.26 45.16% | -4.94K 151,402.45% | |
ev to sales | 11.47 - | |||||||||||
free cash flow per share | -2.06 - | -1.22 40.94% | -0.38 68.96% | -0.64 69.12% | -0.66 3.27% | -0.74 12.30% | -0.76 2.35% | -0.59 22.47% | -0.59 0.35% | -0.44 25.81% | -0.00 99.87% | |
free cash flow yield | -0.13 - | -1.22 808.89% | -0.20 83.66% | -0.29 46.06% | -0.14 53.44% | -0.25 88.33% | -0.16 38.59% | -0.06 62.92% | -0.16 172.81% | -0.28 75.15% | -0.00 99.93% | |
graham net net | 0.37 - | -0.52 239.64% | -0.35 31.49% | 0.24 168.72% | 0.07 71.52% | 2.08 2,908.99% | 0.59 71.49% | 1.64 176.45% | 2.11 28.53% | 1.17 44.33% | 0.00 99.87% | |
graham number | 5.56 - | 4.14 25.44% | 1.74 57.94% | 1.67 4.35% | 1.47 11.56% | 6.05 310.52% | 3.56 41.12% | 5.41 51.79% | 5.59 3.26% | 3.74 33.00% | 0.00 99.88% | |
income quality | 0.74 - | 0.78 4.99% | 0.95 21.46% | 1.36 43.62% | 0.92 32.68% | 0.99 8.51% | 0.85 13.96% | 0.75 12.58% | 0.90 20.63% | 0.84 6.63% | 0.97 14.81% | |
intangibles to total assets | 0.09 - | 0 100% | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -960.91 - | -29.79 - | -51.30 72.20% | 39.66 - | ||||||||
interest debt per share | 0.00 - | 0.01 - | 0.01 15.77% | 0.00 - | 0.01 399.91% | 0.01 49.32% | 0.00 66.74% | 0.00 75.25% | 0.00 99.72% | |||
inventory turnover | ||||||||||||
invested capital | 0.00 - | 0.02 1,629.80% | 0.00 80.59% | 0.00 73.96% | 0.01 1,147.57% | 0.01 46.83% | ||||||
market cap | 42.03M - | 3.11M 92.61% | 6.89M 121.66% | 10.42M 51.28% | 28.97M 178.03% | 22.53M 22.21% | 58.14M 158.02% | 159.00M 173.47% | 77.48M 51.27% | 41.78M 46.08% | 92.49B 221,272.41% | |
net current asset value | 1.09M - | -1.54M 241.34% | -1.24M 19.47% | 1.23M 198.62% | 491K 59.97% | 16.66M 3,292.67% | 7.40M 55.58% | 25.84M 249.19% | 43.91M 69.94% | 31.27M 28.80% | 50.57M 61.74% | |
net debt to ebitda | 0.40 - | 0.04 89.43% | 0.12 183.62% | 0.77 542.25% | 0.32 58.86% | 3.06 867.49% | 0.35 88.70% | 0.58 69.07% | 0.34 41.54% | 0.30 10.82% | 0.21 30.01% | |
net income per share | -2.71 - | -1.55 42.85% | -0.40 74.33% | -0.47 17.96% | -0.72 52.88% | -0.74 3.18% | -0.89 19.96% | -0.78 11.75% | -0.65 16.53% | -0.52 20.96% | -0.00 99.88% | |
operating cash flow per share | -2.01 - | -1.21 40.00% | -0.38 68.82% | -0.64 69.40% | -0.66 2.92% | -0.74 11.96% | -0.76 3.22% | -0.59 22.85% | -0.59 0.69% | -0.44 26.19% | -0.00 99.87% | |
payables turnover | ||||||||||||
receivables turnover | 0.64 - | |||||||||||
research and ddevelopement to revenue | 9.04 - | |||||||||||
return on tangible assets | -2.81 - | -17.11 508.76% | -6.49 62.09% | -1.19 81.70% | -2.36 99.17% | -0.31 86.77% | -1.18 276.21% | -0.44 62.81% | -0.30 31.80% | -0.40 33.25% | -0.36 10.00% | |
revenue per share | 0.06 - | |||||||||||
roe | -5.36 - | 3.15 158.75% | 1.17 62.77% | -1.78 252.07% | -5.33 198.82% | -0.34 93.68% | -1.40 315.10% | -0.47 66.20% | -0.31 34.66% | -0.43 39.18% | -0.38 11.66% | |
roic | -5.38 - | 3.19 159.27% | 1.07 66.32% | -2.01 287.27% | -5.64 180.54% | -0.40 92.88% | -1.46 263.07% | -0.48 66.75% | -0.31 36.09% | -0.43 38.18% | -0.37 12.72% | |
sales general and administrative to revenue | 5.48 - | |||||||||||
shareholders equity per share | 0.51 - | -0.49 197.27% | -0.34 31.07% | 0.26 177.57% | 0.13 48.84% | 2.20 1,533.35% | 0.64 71.10% | 1.66 161.10% | 2.12 27.74% | 1.20 43.21% | 0.00 99.87% | |
stock based compensation to revenue | 1.24 - | |||||||||||
tangible asset value | 1.11M - | -1.53M 237.44% | -1.23M 19.58% | 1.25M 201.34% | 799K 35.87% | 17.02M 2,030.79% | 7.62M 55.26% | 26.01M 241.53% | 44.02M 69.23% | 31.83M 27.71% | 51.06M 60.42% | |
tangible book value per share | 0.41 - | -0.49 220.82% | -0.34 31.07% | 0.26 177.57% | 0.13 48.84% | 2.20 1,533.35% | 0.64 71.10% | 1.66 161.10% | 2.12 27.74% | 1.20 43.21% | 0.00 99.87% | |
working capital | 1.09M - | -1.54M 241.34% | -855.63K 44.60% | 1.23M 243.36% | 491K 59.97% | 16.68M 3,296.33% | 7.52M 54.92% | 25.89M 244.41% | 43.91M 69.60% | 31.67M 27.89% | 50.89M 60.70% |
All numbers in (except ratios and percentages)